On the SGX, Riverstone Holdings stands out for its focus on high-quality nitrile and latex gloves, making its share price a point of interest for those following the medical supplies industry.

The company produces gloves used in healthcare, pharmaceuticals, electronics, and cleanroom environments across Asia, Europe, and the US.

When the pandemic drove up glove demand worldwide, Riverstone’s business and share price both saw a boost.

However, as the here pandemic eased and glove supply caught up with demand, Riverstone’s share price experienced corrections typical in the glove manufacturing sector.

Announcements on new product lines or increased automation in production can also drive investor sentiment.

Fluctuations in latex and nitrile prices, or shifts in global health policies, can impact Riverstone’s profitability and stock performance.

In summary, Riverstone Holdings remains a noteworthy choice for investors interested in healthcare manufacturing and trends in personal protective equipment.